Empower Pharmacy
Contact pharmacy ↗ Request an introduction ↗Patient prescriptions · confirm access
GLP-1 and other peptide compounding is documented for this location. Confirm current availability and state coverage below.
Can this pharmacy serve my state?
Choose your state and service to check shipping and license evidence.
Reported by pharmacy
Matched state-board record. Records also matched in 5 states
Board record checked November 3, 2026“Not confirmed” is a gap in our review, not a finding that the pharmacy is unlicensed or cannot ship.
Shipping scope and restrictions
Empower’s destination pages identify patient-specific prescription shipping in 47 states. Iowa and Wisconsin describe office-use supply, and California has no listed state page. The general FAQ’s all-50-state statement conflicts with these details. This profile follows the state-specific patient-prescription disclosures. Licensure claims are pharmacy-reported.
Confirm your exact medication and delivery address with the pharmacy. A license record does not confirm that every preparation can be shipped.
License records checked (6)
Checked November 3, 2026. These records are specific to this location. General pharmacy, sterile-compounding and outsourcing permits can have different scopes.
- TX · #26444Active
Expires Apr 30, 2027
State board record ↗ - OH · #022339800Active
Expires Mar 31, 2027
State board record ↗ - OK · #99-9114License in Good Standing
Expires Dec 31, 2026
State board record ↗ - CO · #OSP.6131Active
Expires Oct 31, 2028
State board record ↗ - CA · #NRP2567Active
Non Resident Pharmacy
Expires Jan 1, 2027
State board record ↗ - FL · #PH26623Clear
Non-Resident
Expires Feb 28, 2027
State board record ↗
Licenses reported by the pharmacy (47 states)
The pharmacy publishes this list. We have not independently verified every state on it.
Alaska, Alabama, Arkansas, Arizona, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Mississippi, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, West Virginia, Wyoming.
Pharmacy license disclosure ↗Compare all states
Shipping follows the service selected above. License status is checked separately.
Shipping reported for 47 states: Alabama, Alaska, Arizona, Arkansas, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wyoming.
State-board license record matched for California, Colorado, Florida, Ohio, Oklahoma and Texas.
| State | Reported shipping | License status |
|---|
Facility type and oversight
- Facility type
- 503AFacility classification documented in the linked source
- Accreditation
- PCAB · earlier recordRecorded in July 2026 editorial review. Current scope and expiry need reconfirmation.
Check the facility name, address, scope and expiration with the issuer.
Regulatory history
The full inspection and enforcement history has not been reviewed. Any board-action flags found in the checked license records are shown in the coverage section.
Compounding specialties
- GLP-1 compounding
- Documented for this location
- Other peptide compounding
- Documented for this location
Official 503A refrigerated-shipping list includes semaglutide, tirzepatide, glutathione and oxytocin. Texas identifies Suite 100 as the sterile-compounding pharmacy. Suite 200 is central processing.
Organization and scale
- Company or brand
- Empower
- Founded
- Not confirmed
- Company-reported scale
- 15,000 prescriptions/dayHistorical group milestone
Where the information came from
- Facility review evidence ↗November 3, 2026
- Pharmacy shipping report ↗
- 503A semaglutide formulation ↗
- 503A sermorelin formulation ↗
- Patient-specific Texas shipping disclosure ↗
- Iowa office-use disclosure ↗
- Wisconsin office-use disclosure ↗
- Facility identification ↗
- TX licensing authority ↗Facility license · checked November 3, 2026
- OH licensing authority ↗Facility license · checked November 3, 2026
- OK licensing authority ↗Facility license · checked November 3, 2026
- CO licensing authority ↗Facility license · checked November 3, 2026
- CA licensing authority ↗Facility license · checked November 3, 2026
- FL licensing authority ↗Facility license · checked November 3, 2026
Sources and methodology
Services and shipping statements are attributed to their sources; state-board license records are checked separately. Missing information stays unconfirmed. Explore the editorial guide or company research index. Nearby distances use approximate city and ZIP centers from GeoNames under CC BY 4.0. Confirm pickup and current availability directly with the pharmacy.